Literature DB >> 11442264

Influence of crystal structure on the tableting properties of sulfamerazine polymorphs.

C Sun1, D J Grant.   

Abstract

PURPOSE: To understand the influence of polymorphic structure on the tableting properties of sulfamerazine.
METHODS: Bulk powders of sulfamerazine polymorph I and of two batches. II(A) and II(B) of different particle size, of polymorph II were crystallized. The powders were compressed to form tablets whose porosity and tensile strength were measured. The relationships between tensile strength, porosity and compaction pressure were analyzed by the method developed by Joiris. E., et al. Pharm. Res. 15:1122-1130 (1998).
RESULTS: The sensitivity of tensile strength to compaction pressure, known as the tabletability, follows the order. I >> II(A) > II(B) and the porosity at the same compaction pressure, which measures the compressibility, follows the order, I << II(A) < II(B). Therefore. the superior tabletability of I over II(A) or II(B) is attributed to its greater compressibility. Molecular simulation reveals slip planes in crystals of I but not in II. Slip planes provide I crystals greater plasticity and therefore greater compressibility and tabletability. Larger crystal size of II(B) than of II(A) leads to fewer contact points between crystals in the tablets and results in a slightly lower tabletability.
CONCLUSIONS: Slip planes confer greater plasticity to crystals of I than II and therefore greater tabletability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442264     DOI: 10.1023/a:1011038526805

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Mechanical property predictions for polymorphs of sulphathiazole and carbamazepine.

Authors:  R J Roberts; R S Payne; R C Rowe
Journal:  Eur J Pharm Sci       Date:  2000-01       Impact factor: 4.384

2.  Crystallization and transitions of sulfamerazine polymorphs.

Authors:  Geoff G Z Zhang; Chonghui Gu; Mark T Zell; R Todd Burkhardt; Eric J Munson; David J W Grant
Journal:  J Pharm Sci       Date:  2002-04       Impact factor: 3.534

3.  Compression behavior of orthorhombic paracetamol.

Authors:  E Joiris; P Di Martino; C Berneron; A M Guyot-Hermann; J C Guyot
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

4.  Particle slippage and rearrangement during compression of pharmaceutical powders.

Authors:  P York
Journal:  J Pharm Pharmacol       Date:  1978-01       Impact factor: 3.765

5.  Physicochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution.

Authors:  G Nichols; C S Frampton
Journal:  J Pharm Sci       Date:  1998-06       Impact factor: 3.534

6.  Tensile strength of compressed powders and an example of incompatibility as end-point on shear yield locus.

Authors:  E N Hiestand; C B Peot
Journal:  J Pharm Sci       Date:  1974-04       Impact factor: 3.534

7.  The effects of polymorphism, particle size and compression pressure on the dissolution rate of phenylbutazone tablets.

Authors:  M D Tuladhar; J E Carless; M P Summers
Journal:  J Pharm Pharmacol       Date:  1983-05       Impact factor: 3.765

8.  Effect of compression temperature on the consolidation mechanism of chlorpropamide polymorphs.

Authors:  M Otsuka; T Matsumoto; S Higuchi; K Otsuka; N Kaneniwa
Journal:  J Pharm Sci       Date:  1995-05       Impact factor: 3.534

9.  Studies on the characteristics of carbochromen hydrochloride crystals. II. Polymorphism and cracking in the tablets.

Authors:  T Yamaoka; H Nakamachi; K Miyata
Journal:  Chem Pharm Bull (Tokyo)       Date:  1982-10       Impact factor: 1.645

10.  On the direct compression of sulfamethoxydiazine (SMD) polymorphic forms - I.

Authors:  U Conte; P Colombo; C Caramella; G P Bettinetti; F Giordano; A La Manna
Journal:  Farmaco Prat       Date:  1975-04
  10 in total
  16 in total

1.  Elucidating raw material variability--importance of surface properties and functionality in pharmaceutical powders.

Authors:  Sai P Chamarthy; Rodolfo Pinal; M Teresa Carvajal
Journal:  AAPS PharmSciTech       Date:  2009-06-05       Impact factor: 3.246

2.  Effect of particle size on in-die and out-of-die compaction behavior of ranitidine hydrochloride polymorphs.

Authors:  Kailas S Khomane; Arvind K Bansal
Journal:  AAPS PharmSciTech       Date:  2013-07-30       Impact factor: 3.246

3.  Understanding the Tabletability Differences between Indomethacin Polymorphs Using Powder Brillouin Light Scattering.

Authors:  Beth A Young; Dherya Bahl; Lewis L Stevens
Journal:  Pharm Res       Date:  2019-08-19       Impact factor: 4.200

4.  Overcoming poor tabletability of pharmaceutical crystals by surface modification.

Authors:  Limin Shi; Changquan Calvin Sun
Journal:  Pharm Res       Date:  2011-06-28       Impact factor: 4.200

Review 5.  Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.

Authors:  Indumathi Sathisaran; Sameer Vishvanath Dalvi
Journal:  Pharmaceutics       Date:  2018-07-31       Impact factor: 6.321

6.  Investigation of solid phase composition on tablet surfaces by grazing incidence X-ray diffraction.

Authors:  Vishal Koradia; Mikko Tenho; Heidi Lopez de Diego; Michiel Ringkjøbing-Elema; Jørn Møller-Sonnergaard; Jarno Salonen; Vesa-Pekka Lehto; Jukka Rantanen
Journal:  Pharm Res       Date:  2011-07-09       Impact factor: 4.200

7.  Influence of crystal structure on the compaction properties of n-alkyl 4-hydroxybenzoate esters (parabens).

Authors:  Yushi Feng; David J W Grant
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

8.  Crystalline form information from multiwell plate salt screening by use of Raman microscopy.

Authors:  Takashi Kojima; Satomi Onoue; Noriaki Murase; Fumie Katoh; Takashi Mano; Yoshihisa Matsuda
Journal:  Pharm Res       Date:  2006-04-06       Impact factor: 4.200

9.  Amorphous solid dispersions of sulfonamide/Soluplus® and sulfonamide/PVP prepared by ball milling.

Authors:  Vincent Caron; Yun Hu; Lidia Tajber; Andrea Erxleben; Owen I Corrigan; Patrick McArdle; Anne Marie Healy
Journal:  AAPS PharmSciTech       Date:  2013-02-07       Impact factor: 3.246

10.  Improved tableting properties of p-hydroxybenzoic acid by water of crystallization: a molecular insight.

Authors:  Changquan Sun; David J W Grant
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.